Ten-year experience with the Perceval S sutureless prosthesis: lessons learned and future perspectives.

Journal of visualized surgery Pub Date : 2018-05-03 eCollection Date: 2018-01-01 DOI:10.21037/jovs.2018.03.10
Vincent Chauvette, Amine Mazine, Denis Bouchard
{"title":"Ten-year experience with the Perceval S sutureless prosthesis: lessons learned and future perspectives.","authors":"Vincent Chauvette,&nbsp;Amine Mazine,&nbsp;Denis Bouchard","doi":"10.21037/jovs.2018.03.10","DOIUrl":null,"url":null,"abstract":"<p><p>Aortic stenosis has traditionally been addressed with surgical aortic valve replacement (AVR). In recent years, several technologies have emerged as alternative treatment methods for aortic valve disease. Among them, the Perceval (LivaNova, London, UK) is a sutureless valve that has been used in clinical practice for over 10 years. It has been implanted in over 20,000 patients worldwide. With nearly 600 Perceval implants since 2011, the Montreal Heart Institute has developed a worldwide expertise with this technology. In this article, we provide an overview of the clinical data currently available in the literature and discuss the lessons we have learned from our experience with the Perceval prosthesis.</p>","PeriodicalId":17587,"journal":{"name":"Journal of visualized surgery","volume":"4 ","pages":"87"},"PeriodicalIF":0.0000,"publicationDate":"2018-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.21037/jovs.2018.03.10","citationCount":"15","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of visualized surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21037/jovs.2018.03.10","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2018/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 15

Abstract

Aortic stenosis has traditionally been addressed with surgical aortic valve replacement (AVR). In recent years, several technologies have emerged as alternative treatment methods for aortic valve disease. Among them, the Perceval (LivaNova, London, UK) is a sutureless valve that has been used in clinical practice for over 10 years. It has been implanted in over 20,000 patients worldwide. With nearly 600 Perceval implants since 2011, the Montreal Heart Institute has developed a worldwide expertise with this technology. In this article, we provide an overview of the clinical data currently available in the literature and discuss the lessons we have learned from our experience with the Perceval prosthesis.

Abstract Image

Abstract Image

使用Perceval S无缝线假体的十年经验:经验教训和未来展望。
主动脉瓣狭窄传统上是通过手术主动脉瓣置换术(AVR)来解决的。近年来,出现了几种技术作为主动脉瓣疾病的替代治疗方法。其中,Perceval (LivaNova, London, UK)是一种无缝线瓣膜,已在临床应用超过10年。全世界已经有超过2万名患者植入了它。自2011年以来,蒙特利尔心脏研究所(Montreal Heart Institute)已经植入了近600个珀西瓦尔(Perceval)心脏,并在全球范围内发展了这项技术。在这篇文章中,我们概述了目前文献中可用的临床数据,并讨论了我们从使用Perceval假体的经验中学到的教训。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.40
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信